EHang Joins International Project to Develop Air Ambulance
21 août 2020 08h30 HE
|
EHang Holdings Limited
GUANGZHOU, China, Aug. 21, 2020 (GLOBE NEWSWIRE) -- EHang Holdings Limited (Nasdaq: EH) (“EHang” or the “Company”), the world's leading autonomous aerial vehicle (“AAV”) technology platform company,...
EHang to Report Second Quarter 2020 Unaudited Financial Results on Tuesday, August 25, 2020
18 août 2020 08h30 HE
|
EHang Holdings Limited
GUANGZHOU, China, Aug. 18, 2020 (GLOBE NEWSWIRE) -- EHang Holdings Limited (“EHang” or the “Company” ) (Nasdaq: EH), the world’s leading autonomous aerial vehicle (“AAV”) technology platform...
EHang Drives Forward UAM Implementation in Europe
14 août 2020 09h15 HE
|
EHang Holdings Limited
- UAM pilot city partnership with Linz, Austria - EHang 216 autonomous aerial vehicle to take off in Linz soon VIENNA, Austria, Aug. 14, 2020 (GLOBE NEWSWIRE) -- EHang Holdings Limited (Nasdaq:...
Freeline Announces Pricing of Initial Public Offering
07 août 2020 02h49 HE
|
Freeline Therapeutics
LONDON, Aug. 07, 2020 (GLOBE NEWSWIRE) -- Freeline Therapeutics Holdings plc (“Freeline”), a clinical-stage, fully integrated, next generation, systemic AAV-based gene therapy company with the...
Freeline Launches Roadshow for Initial Public Offering
03 août 2020 06h30 HE
|
Freeline Therapeutics
LONDON, Aug. 03, 2020 (GLOBE NEWSWIRE) -- Freeline Therapeutics Holdings plc (“Freeline”), a clinical-stage, fully integrated, next generation, systemic AAV-based gene therapy company with the...
EHang 216 Obtained Special Flight Operations Certificate from Transport Canada Civil Aviation
29 juil. 2020 08h59 HE
|
EHang Holdings Limited
GUANGZHOU, China, July 29, 2020 (GLOBE NEWSWIRE) -- EHang Holdings Limited (Nasdaq: EH) (“EHang” or the “Company”), the world's leading autonomous aerial vehicle (AAV) technology platform company,...
Freeline files registration statement for proposed initial public offering in the United States
20 juil. 2020 02h00 HE
|
Freeline Therapeutics
LONDON, July 20, 2020 (GLOBE NEWSWIRE) -- Freeline, a clinical-stage, fully integrated, next generation, systemic AAV-based gene therapy company with the ambition of transforming the lives of...
Freeline presents new Haemophilia B data at the International Society on Thrombosis and Haemostasis (ISTH) 2020 Meeting
13 juil. 2020 11h45 HE
|
Freeline Therapeutics
- Updated FLT180a data in the B-AMAZE study in severe Haemophilia B patients demonstrated the potential for sustained normal FIX activity levels - - Additional data were presented in 5 poster...
Abeona Therapeutics Announces Appointment of Michael Amoroso as Chief Commercial Officer
09 juil. 2020 07h30 HE
|
Abeona Therapeutics Inc.
NEW YORK and CLEVELAND, July 09, 2020 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, today announced the appointment of Michael...
Abeona Therapeutics Reinitiates Enrollment in EB-101 Pivotal Phase 3 VIITAL™ Study in RDEB after COVID-19 Related Pause and Announces Progress in Patient Enrollment in MPS III Studies
08 juil. 2020 07h30 HE
|
Abeona Therapeutics Inc.
NEW YORK and CLEVELAND, July 08, 2020 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, today announced recent updates on its clinical...